Document is current
Any future updates will be listed below
-
Authors
Liu, Menglu
Li, Jiawen
Yan, Kailun
Zhang, Kexin
Zhu, Pei
Tang, Xiaofang
Yuan, Deshan
Yang, Yuejin
Gao, Runlin
Yuan, Jinqing
Zhao, Xueyan
-
Funding
Funding for this research was provided by:
Basic Research Key Project of the XPCC Natural Science Support Plan (2024DA013, 2024DA013, 2024DA013, 2024DA013, 2024DA013, 2024DA013, 2024DA013, 2024DA013, 2024DA013, 2024DA013, 2024DA013)
the National High Level Hospital Clinical Research Funding (2023-GSP-GG-40, 2023-GSP-GG-40, 2023-GSP-GG-40, 2023-GSP-GG-40, 2023-GSP-GG-40, 2023-GSP-GG-40, 2023-GSP-GG-40, 2023-GSP-GG-40, 2023-GSP-GG-40, 2023-GSP-GG-40, 2023-GSP-GG-40)
CS Optimizing Antithrombotic Research Fund (BJUHFCSOARF201801-06, BJUHFCSOARF201801-06, BJUHFCSOARF201801-06, BJUHFCSOARF201801-06, BJUHFCSOARF201801-06, BJUHFCSOARF201801-06, BJUHFCSOARF201801-06, BJUHFCSOARF201801-06, BJUHFCSOARF201801-06, BJUHFCSOARF201801-06, BJUHFCSOARF201801-06)
CAMS Innovation Fund for Medical Sciences (2023-I2M-1-002, 2023-I2M-1-002, 2023-I2M-1-002, 2023-I2M-1-002, 2023-I2M-1-002, 2023-I2M-1-002, 2023-I2M-1-002, 2023-I2M-1-002, 2023-I2M-1-002, 2023-I2M-1-002, 2023-I2M-1-002)
- License Information
-
More Information
Article History
Received: 3 December 2024
Accepted: 25 April 2025
First Online: 13 May 2025
Declarations
:
: The studies involving human participants were reviewed and approved by the Fuwai hospital institutional review board (approval number: 2013 − 449). The patients/participants provided written informed consent to participate in this study.
: All the authors have approved the manuscript that is enclosed for publication.
: The authors declare no competing interests.
